Back HIV/AIDS HIV/AIDS Topics HIV Prevention

CROI 2012: Conference Overview Highlights Biomedical HIV Prevention

HIV prevention was the key theme at Monday's opening press overview of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), taking place this week in Seattle.alt

Read more:

Conference on Retroviruses and Opportunistic Infections Opens Next Week in Seattle

The 19th Conference on Retroviruses and Opportunistic Infections -- better known as the Retrovirus conference or CROI -- will take place next week, March 5-8, at the Washington State Convention Center in Seattle. HIVandHepatitis.com will be on site to provide breaking news, analysis, and video coverage.alt

Read more:

Vacc-4x Therapeutic HIV Vaccine Linked to Lower Viral Load in Phase IIb Study

An experimental therapeutic vaccine reduced HIV viral load among patients who remained off antiretroviral therapy (ART) for up to 24 weeks, suggesting it effectively stimulates the immune system's response to the virus, according to study finding released last week by Bionor Pharma, a Norwegian biotech company.alt

Read more:

WHO Affirms That Women at Risk for HIV Should Continue To Use Injectable Contraceptives

The World Health Organization (WHO) has affirmed its 2009 policy that women living with or at risk for HIV should continue to use hormonal contraception, despite conflicting results from recent studies suggesting that oral or injectable hormones may increase the risk of HIV infection.alt

Read more:

HIV Viral Load Predicts Risk of Infection in Large Study

HIV RNA levels are the most significant factor predicting risk of HIV transmission, according to a study reported in the February 1, 2012, Journal of Infectious Diseases. Condom use, adult male circumcision, and concurrent sexually transmitted infections (STIs) were also important factors.

Read more: